Wise Prostate-specific Antigen Testing Means a Limited, Risk-adjusted, and Personal Approach
Eur Urol
.
2023 Oct;84(4):359-360.
doi: 10.1016/j.eururo.2023.05.022.
Epub 2023 Jun 7.
Authors
Eveline A M Heijnsdijk
1
,
Harry J de Koning
2
Affiliations
1
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands. Electronic address: e.heijnsdijk@erasmusmc.nl.
2
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
PMID:
37296041
DOI:
10.1016/j.eururo.2023.05.022
No abstract available
Publication types
Editorial
Comment
MeSH terms
Early Detection of Cancer
Humans
Male
Prostate-Specific Antigen*
Prostatic Neoplasms* / diagnosis
Substances
Prostate-Specific Antigen